TITLE

`Octopus' Aids Open-Heart Surgery

PUB. DATE
February 1999
SOURCE
USA Today Magazine;Feb99, Vol. 127 Issue 2645, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Discusses the benefits of Octopus, a piece of equipment that allows surgeons to perform open-heart surgery on a beating heart. How the instrument is used; How traditional open heart surgery is performed; Comparison between surgery with Octopus and the traditional open heart surgery.
ACCESSION #
1561377

Tags: HEART -- Surgery -- Instruments;  SURGICAL instruments & apparatus

 

Related Articles

  • Here Come the Snake-Bots. Lametti, Daniel // Discover;Nov2010, Vol. 31 Issue 9, p18 

    The article focuses on the Cardio Arm, a serpentine robot invented in part by roboticist Howie Choset that is used to assist surgery in hard-to-reach places in the heart.

  • Patients, doctors take heart in polycarbonate atrial depressor.  // Canadian Plastics;Jun2006, Vol. 64 Issue 6, p33 

    The article features the Lexan HPM 1914 polycarbonate resin from GE Plastics which make up Estech's ClearView MV Atrial Depressor. The resistance of Lexan HPM to fracturing makes the ClearView more reliable to surgeons to operate. The material was also easy to sterilize and offers good...

  • Diverse experience with the CardioSEAL� and STARFlex� septal occluders. Apostolopoulou, Sotiria C.; Laskari, Cleo V.; Kiaffas, Maria; Papagiannis, John; Rammos, Spyridon // Cardiology in the Young;Aug2004, Vol. 14 Issue 4, p367 

    Apart from closure of atrial septal defects, there is little information concerning the use of the CardioSEAL family of occluders in congenitally malformed hearts. We review here our initial experience using the CardioSEAL and STARFlex occluders in 12 patients aged 17.3 � 11.2 years, with a...

  • Guidant hears kudos for carotid artery product. Murphy, Tom // Indianapolis Business Journal;9/13/2004, Vol. 25 Issue 27, p8A 

    Reports that the U.S. Food and Drug Administration has approved Guidant Corp.'s carotid artery stent product for use in stroke prevention. Outlook for the carotid stent market; Financial performance of the medical device manufacturer for the first six-months of 2004; Price of the stents; Sales...

  • Acorn gets new heartfailure device trial.  // Medical Technology & Devices Week;5/14/2007, Vol. 5 Issue 20, p5 

    The article reports on the decision of the U.S. Food and Drug Administration (FDA) to allow Acorn Cardiovascular to conduct another clinical trial of its CorCap cardiac support device. FDA has rejected the approval of CorCap arguing that more study is needed to prove that the device is safe and...

  • Percutaneous treatment of coronary bifurcation lesions: a novel "extended Y" technique with complete lesion stent coverage. Helqvist, S; Jørgensen, E.; Kelbaek, H.; Aljabbari, S.; Thuesen, L.; Lassen, J. Flensted; Saunamäki, K. // Heart;Jul2006, Vol. 92 Issue 7, p981 

    The article presents a study on the percutaneous treatment of coronary bifurcation lesions using the extended Y technique. Researchers invented the extended Y technique using conventional stent systems. The novel technique for percutaneous coronary intervention in coronary artery bifurcation...

  • Turkish Scientist Develops Special Needle and Thread For Heart Surgeries.  // Journal of Turkish Weekly;6/15/2009, p67 

    The article reports on a special type of surgical thread and needles for heart surgeries that were developed by Turkish scientist Murat Dikmengil. The needles and thread, which were manufactured in Germany, were developed in an effort to shorten the length and increase the success rates of heart...

  • Product pipeline.  // Cardiovascular Devices & Drugs;Jun2008, Vol. 14 Issue 6, p36 

    The article focuses on a study which examined the safety and effectiveness of the Zilver PTX drug-eluting peripheral stent (DES), manufactured by Cook Medical, in treating peripheral arterial disease (PAD). The study compared the effectiveness of DES with percutaneous transluminal angioplasty....

  • The distance from the Amplatzer septal occluder to the mitral valve in patients undergoing interventional closure of defects in the oval fossa increases with growth of the patient. English, Robert F.; Ettedgui, Jose A. // Cardiology in the Young;Oct2004, Vol. 14 Issue 5, p494 

    The Amplatzer septal occluder is an alternative to operative closure of atrial septal defects within the oval fossa. An issue when deploying the device is its distance from the mitral valve. The purpose of this study is to determine how this distance changes with growth of the patient. We...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics